- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-2-mer
- Ligands
- 16 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Non-functional Binders)(Post Translational Modification)(Non-covalent)
- 5 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.6: 4 residues within 4Å:- Chain A: N.1095, T.1097, H.1098, F.1100
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.12: 4 residues within 4Å:- Chain B: N.1095, T.1097, H.1098, F.1100
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.13: 2 residues within 4Å:- Chain B: I.1129, N.1131
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.20: 3 residues within 4Å:- Chain C: N.1095, H.1098, F.1100
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:H.1098
NAG-NAG-BMA.21: 1 residues within 4Å:- Chain C: N.1131
No protein-ligand interaction detected (PLIP)- 34 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)(Post Translational Modification)(Non-functional Binders)
NAG.22: 2 residues within 4Å:- Chain A: V.16, S.253
Ligand excluded by PLIPNAG.23: 3 residues within 4Å:- Chain A: C.15, N.17, N.135
Ligand excluded by PLIPNAG.24: 5 residues within 4Å:- Chain A: D.336, F.339, N.340, L.365, L.368
Ligand excluded by PLIPNAG.25: 2 residues within 4Å:- Chain A: Y.28, N.61
Ligand excluded by PLIPNAG.26: 1 residues within 4Å:- Chain A: N.600
Ligand excluded by PLIPNAG.27: 1 residues within 4Å:- Chain A: N.654
Ligand excluded by PLIPNAG.28: 3 residues within 4Å:- Chain A: N.613, C.614, Q.641
Ligand excluded by PLIPNAG.29: 1 residues within 4Å:- Chain A: N.706
Ligand excluded by PLIPNAG.30: 4 residues within 4Å:- Chain B: N.120, A.121, T.122, N.123
Ligand excluded by PLIPNAG.31: 2 residues within 4Å:- Chain B: N.143, S.251
Ligand excluded by PLIPNAG.32: 4 residues within 4Å:- Chain B: C.15, N.17, C.134, N.135
Ligand excluded by PLIPNAG.33: 6 residues within 4Å:- Chain B: Y.377, G.378, A.408, P.409, F.426, T.427
Ligand excluded by PLIPNAG.34: 2 residues within 4Å:- Chain B: Y.28, N.61
Ligand excluded by PLIPNAG.35: 2 residues within 4Å:- Chain B: N.600, T.601
Ligand excluded by PLIPNAG.36: 1 residues within 4Å:- Chain B: N.654
Ligand excluded by PLIPNAG.37: 3 residues within 4Å:- Chain B: N.613, T.615, Q.641
Ligand excluded by PLIPNAG.38: 1 residues within 4Å:- Chain B: N.706
Ligand excluded by PLIPNAG.39: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPNAG.40: 1 residues within 4Å:- Chain C: S.251
Ligand excluded by PLIPNAG.41: 3 residues within 4Å:- Chain C: N.17, T.19, N.135
Ligand excluded by PLIPNAG.42: 4 residues within 4Å:- Chain C: F.335, D.336, F.339, N.340
Ligand excluded by PLIPNAG.43: 2 residues within 4Å:- Chain C: Y.28, N.61
Ligand excluded by PLIPNAG.44: 1 residues within 4Å:- Chain C: N.600
Ligand excluded by PLIPNAG.45: 3 residues within 4Å:- Chain C: Y.652, V.653, N.654
Ligand excluded by PLIPNAG.46: 3 residues within 4Å:- Chain C: N.613, C.614, Q.641
Ligand excluded by PLIPNAG.47: 2 residues within 4Å:- Chain B: Y.793
- Chain C: N.706
Ligand excluded by PLIPNAG.48: 3 residues within 4Å:- Chain D: K.398, S.402, N.528
Ligand excluded by PLIPNAG.49: 2 residues within 4Å:- Chain D: N.72, L.73
Ligand excluded by PLIPNAG.50: 4 residues within 4Å:- Chain D: E.294, N.304, M.305, W.310
Ligand excluded by PLIPNAG.51: 3 residues within 4Å:- Chain D: T.34, N.35, Q.322
Ligand excluded by PLIPNAG.52: 4 residues within 4Å:- Chain E: H.399, S.402, S.527, N.528
Ligand excluded by PLIPNAG.53: 1 residues within 4Å:- Chain E: N.72
Ligand excluded by PLIPNAG.54: 2 residues within 4Å:- Chain E: V.298, N.304
Ligand excluded by PLIPNAG.55: 3 residues within 4Å:- Chain E: T.34, N.35, E.39
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cui, Z. et al., Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron. Cell (2022)
- Release Date
- 2022-06-22
- Peptides
- Spike glycoprotein: ABC
Processed angiotensin-converting enzyme 2: DE - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
F
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-2-mer
- Ligands
- 16 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Non-functional Binders)(Post Translational Modification)(Non-covalent)
- 5 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 34 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)(Post Translational Modification)(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cui, Z. et al., Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron. Cell (2022)
- Release Date
- 2022-06-22
- Peptides
- Spike glycoprotein: ABC
Processed angiotensin-converting enzyme 2: DE - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
F